Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?
Open Access
- 23 May 2020
- journal article
- review article
- Published by Elsevier BV in Journal of Microbiology, Immunology and Infection
- Vol. 53 (4), 505-512
- https://doi.org/10.1016/j.jmii.2020.05.013
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Severe community-acquired pneumonia due to Pseudomonas aeruginosa coinfection in an influenza A(H1N1)pdm09 patientJournal of Microbiology, Immunology and Infection, 2019
- Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal InfluenzaaClinical Infectious Diseases, 2018
- Molecular epidemiology and clinical features of rhinovirus infections among hospitalized patients in a medical center in TaiwanJournal of Microbiology, Immunology and Infection, 2018
- High-level ambient particulate matter before influenza attack with increased incidence of Aspergillus antigenemia in Southern Taiwan, 2016Journal of Microbiology, Immunology and Infection, 2018
- Syndromic Panel-Based Testing in Clinical MicrobiologyClinical Microbiology Reviews, 2018
- Critically Ill Patients With the Middle East Respiratory Syndrome: A Multicenter Retrospective Cohort StudyCritical Care Medicine, 2017
- Middle East Respiratory Syndrome Coronavirus and Pulmonary Tuberculosis Coinfection: Implications for Infection ControlIntervirology, 2017
- The impact of co-infection of influenza A virus on the severity of Middle East Respiratory Syndrome CoronavirusJournal of Infection, 2017
- Epidemiology of human coronavirus NL63 infection among hospitalized patients with pneumonia in TaiwanJournal of Microbiology, Immunology and Infection, 2015
- Co-circulation of human metapneumovirus and SARS-associated coronavirus during a major nosocomial SARS outbreak in Hong KongJournal of Clinical Virology, 2007